U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07035405) titled 'Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX)' on June 05.
Brief Summary: The role of colchicine in the secondary prevention of ischemic stroke has not been determinded. This multicenter, randomized, double-blind, placebo-controlled, event-driven clinical trial of CHANCE-3 EX was aimed to assess the efficacy and safety of low-dose colchicine versus placebo on reducing the risk of recurrent ischemic stroke, myocardial infarction and vascular death in patients with minor-to-moderate ischemic stroke.
Study Start Date: July 04
Study Type: INTERVENTIONAL
Condition:
Stroke
Intervention:
DRUG: Colchicine 0.5...